Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab? (2018)
Attributed to:
The Role of Membrane Attack Complex in Atypical Haemolytic Uraemic Syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21037/atm.2018.10.35
PubMed Identifier: 30613637
Publication URI: http://europepmc.org/abstract/MED/30613637
Type: Journal Article/Review
Volume: 6
Parent Publication: Annals of translational medicine
Issue: Suppl 1
ISSN: 2305-5839